Impact Biomedical annual return on equity
2023
2024
2025
Impact Biomedical Return on Equity (ROE) Growth & History (IBO)
Impact Biomedical's return on equity was −142.88% for fiscal 2025.
View full Impact Biomedical company overviewImpact Biomedical annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −142.88% | +24.74 pp |
| 2024 | 2024-12-31 | −167.62% | −151.79 pp |
| 2023 | 2023-12-31 | −15.83% | — |
Impact Biomedical quarterly return on equity
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −6.29% | — |
| Q1 2026 | 2026-03-31 | −19.24% | +12.04 pp |
| Q4 2025 | 2025-12-31 | 2,089.64% | +2241.88 pp |
| Q1 2025 | 2025-03-31 | −31.28% | −27.39 pp |
| Q4 2024 | 2024-12-31 | −152.24% | −147.64 pp |
| Q3 2024 | 2024-09-30 | 15.52% | +19.87 pp |
| Q2 2024 | 2024-06-30 | −3.73% | +0.19 pp |
| Q1 2024 | 2024-03-31 | −3.89% | — |
| Q4 2023 | 2023-12-31 | −4.60% | — |
| Q3 2023 | 2023-09-30 | −4.35% | — |
| Q2 2023 | 2023-06-30 | −3.92% | — |
Impact Biomedical return on equity trends
Between the periods ended 2023-12-31 and 2025-12-31, Impact Biomedical's return on equity decreased from −15.83% to −142.88%, a change of −127.05 percentage points. The latest reported quarter, Q2 2026, shows −6.29%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Impact Biomedical source filings ↗